Korean J Med.
2004 Apr;66(4):437-441.
A case of therapy-related acute lymphoblastic leukemia after 131I -treatment for thyroid papillary carcinoma
- Affiliations
-
- 1Department of Internal Medicine, College of Medicine, Seoul National University, Seoul, Korea. ssysmc@snu.ac.kr
Abstract
- During the last decade the issue of therapy-related myelodysplasia (t-MDS) and acute myeloid leukemia (t-AML) following high-dose chemotherapy (HD-CT) and autologous stem cell transplantation (ASCT) or conventional chemotherapy, radiotherapy for malignant diseases has become increasingly important. The number of patients with hematologic malignancies and chemosensitive or radiosensitive solid tumors undergoing this new type of treatment has expanded dramatically. Recently, we experienced a case of 35-year-old female patient with therapy-related acute lymphoblastic leukemia (t-ALL) after 131I treatment for thyroid papillary carcinoma. Total 131I dose the patient received was 900mCi and patient was diagnosed as having ALL 11 months after last 131I treatment. Although the prognosis of therapy-related acute leukemia/myelodysplastic syndrome is poor, the patient is alive in complete remission after allogeneic bone marrow transplantation from HLA-matched sibling donor. Given the rarity of this case, we report the case with literature reviews.
MeSH Terms
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Precursor B-Cell Acute Lymphoblastic Leukemia in Two Patients with a History of Cytotoxic Therapy
- A Case of Acute Promyelocytic Leukemia after Iodine-131 Treatment for Thyroid Cancer
- Concurrent Medullay and Papillary Carcinoma of the Thyroid
- A Case of Scalp Metastasis from Papillary Thyroid Carcinoma
- Two Cases of Thyroid Tumor after Radiation Therapy of Primary Malignancy
